Related Experiment Video
Updated: May 8, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Predicting Pharmacokinetic Variability and Drug Interaction Risk Using Omics-Based Biomarkers.
1Division of Translation and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Clinical and Translational Science
|May 7, 2026
Summary
Understanding drug variability is key for precision dosing. Phenotypic biomarkers offer a proactive approach to predict drug exposure and interactions, improving individualized medicine beyond genetics.
Area of Science:
- Pharmacology
- Precision Medicine
- Biomarker Discovery
Background:
- Interindividual variability in drug pharmacokinetics and drug-drug interactions hinders precision dosing, especially for narrow therapeutic index drugs.
- While genetics play a role, dynamic factors like physiology, disease, age, diet, microbiome, and medications significantly contribute to this variability.
- Current methods offer limited retrospective insights into drug behavior.
Purpose of the Study:
- To introduce phenotypic biomarkers as a proactive strategy for quantifying drug variability.
- To demonstrate the potential of biomarkers in improving drug exposure prediction and assessing interaction risks.
- To advance individualized dosing strategies beyond traditional pharmacogenomic approaches.
Main Methods:
- Utilizing emerging phenotypic biomarkers.
- Quantifying interindividual variability in drug pharmacokinetics.
- Assessing susceptibility to drug-drug interactions.
Main Results:
- Phenotypic biomarkers provide a mechanism-based approach to understand drug variability.
- These biomarkers enable proactive risk assessment for drug interactions.
- The strategy supports individualized dosing tailored to dynamic patient factors.
Conclusions:
- Phenotypic biomarkers represent a significant advancement in precision dosing.
- They offer a proactive, mechanism-based method to manage drug variability and interactions.
- This approach moves beyond pharmacogenomics for more personalized therapeutic strategies.
Related Concept Videos
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...